Trial ID or NCT#
A research study of the drug amrubicin in patients with cancer of the thymus (thymoma or thymic carcinoma). We hope to learn whether this drug is an effective and safe treatment for thymic cancers.
A Phase II Study of Amrubicin in Relapsed or Refractory Thymic Malignancies
Contact us to find out if this trial is right for you.